Injection ports permit repeated access to IV lines and catheters. The global injection port market is estimated to be valued at US$ 1.57 Bn in 2024 and is expected to exhibit a CAGR of 7.6% over the forecast period 2024 to 2030.
The injection port market is driven by the growing pharmaceutical industry globally. Injection ports find widespread application in pharmaceutical drug manufacturing and drug delivery processes for easy filling, transfer and withdrawing of fluids at various stages. They help increase efficiency and productivity while reducing human error and risk of contamination in comparison to conventional methods. The Single-Use Injection Ports are widely gaining popularity as they eliminate the cleaning and sterilization steps required for multi-use injection ports.
Key Takeaways
Key players operating in the injection port market are Jungbunzlauer, Gadot Biochemical Industries, Sucroal, Dr. Paul Lohmann, Global Calcium, TATE & LYLE, American Elements, Triveni Chemicals, A.B. Enterprises, Nikunj Chemicals, Advait Industries, Anmol Chemicals, Krishna Chemicals, AMS biotechnology, Henan Honghui Biotechnology.
The key opportunities in the market include rising demand for prefilled syringes and injectable drug delivery systems from the biopharmaceutical industry. Growing preference for self-administered injection devices and disposable medical devices also presents significant growth prospects.
North America currently dominates the global injection port market followed by Europe and Asia Pacific. However, Asia Pacific is expected to witness highest growth owing to growing pharmaceutical manufacturing in countries like China, India and Japan and increasing healthcare spending. Key players are expanding their manufacturing and distribution footprint in emerging economies of Asia Pacific and Latin America to tap into new revenue streams.
Market Drivers
- Increasing demand for efficient drug delivery devices from pharmaceutical manufacturers to streamline production processes.
- Rising prevalence of chronic diseases and growing geriatric population requiring injection-based drug therapies.
Market Restraints
- Availability of alternative products like prefilled syringes, vials and ampoules limits the demand for injection ports to some extent.
- Concerns regarding leachable and extractable of silicone and other materials used in injection ports hampers their adoption.
Segment Analysis
The injection port market is dominated by the plastic segment. The plastic injection ports account for over 60% of the total market share owing to their lightweight and relatively cheaper price as compared to other materials such as glass and metal. Plastic ports are used in large volumes in pharmaceutical and food & beverage applications. The high durability and leak-proof nature of plastic ports have increased their preference among manufacturers in these industries.
The pharmaceutical segment holds the largest share of over 30% of the total injection port market. Injection ports are predominantly used for filling liquid pharmaceutical drugs in vials and ampoules. Their non-reactive and sterilizable properties assure contamination-free drug filling. The expansion of the pharmaceutical industry and growing demand for portable injections are expected to drive the demand for injection ports from this segment.
Global Analysis
On the basis of region, the Asia Pacific region dominates the global injection port market and is expected to maintain its leading position during the forecast period. China and India are the top contributors to the regional market growth. Both countries have established themselves as major pharmaceutical manufacturing hubs. The availability of generic drugs at competitive prices has boosted pharmaceutical production in these nations. This, in turn, has augmented the demand for injection ports for manufacturing operations.
North America stands as the second largest market for injection ports stimulated by robust pharmaceutical and food industries in the United States. Strong support from government organizations to promote medical research and drug development programs in the US augurs well for the regional market.
Comments
0 comment